Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Indivior reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-03 | -$2.64 (-6.60%) | $4.48 (11.20%) | -$0.87 (-2.33%) | $2.28 (6.10%) |
| 2026-04-30 | +$2.63 (+7.70%) | $4.40 (12.88%) | +$0.88 (+2.39%) | $2.94 (7.99%) |
| 2026-02-26 | +$0.08 (+0.24%) | $3.00 (8.92%) | -$0.99 (-2.94%) | $1.79 (5.30%) |
| 2025-10-30 | +$3.89 (+15.41%) | $2.55 (10.10%) | +$0.24 (+0.82%) | $1.50 (5.15%) |
| 2025-07-31 | +$2.80 (+16.09%) | $1.70 (9.77%) | +$0.85 (+4.21%) | $1.34 (6.63%) |
| 2025-04-24 | +$1.31 (+13.86%) | $0.71 (7.51%) | +$0.80 (+7.43%) | $1.06 (9.85%) |
| 2025-02-20 | -$1.92 (-17.60%) | $0.71 (6.51%) | -$0.54 (-6.01%) | $0.63 (7.06%) |
| 2024-10-24 | +$0.21 (+2.45%) | $0.64 (7.48%) | +$0.23 (+2.62%) | $0.30 (3.48%) |
| Avg Abs Move | 9.99% | 9.30% | 3.59% | 6.45% |
Historical price behavior shows significant volatility around earnings releases, with an average absolute Day 0 move of 9.99% and typical intraday range of 9.30%. The stock has demonstrated explosive upside potential, posting Day 0 gains of 15.41% and 16.09% following the past two October and July reports, respectively. However, the most recent August report triggered a sharp 6.60% decline despite the company's substantial earnings beat, highlighting that even strong results don't guarantee positive price action. Day +1 follow-through has been more modest, averaging 3.59% with a 6.45% range, suggesting most of the volatility concentrates in the immediate reaction session. Investors should prepare for a potential double-digit percentage swing in either direction when results hit the tape Thursday morning.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 23) |
| Expected Move | $0.00 (0.00%) |
| Expected Range | $34.77 to $34.77 |
| Implied Volatility | 73.31% |
The options market is not pricing in a significant expected move for the November expiration, with an implied move of 0.00% that falls well below the stock's 9.99% average historical Day 0 earnings move. This disconnect suggests options traders may be underestimating potential volatility, or the lack of options activity reflects limited hedging interest ahead of this release.
Analysts maintain a Strong Buy consensus on Indivior, with all 5 analysts rating the stock a Strong Buy and zero hold or sell ratings. This represents improved sentiment from one month ago, when the breakdown was 4 Strong Buys and 1 Hold, indicating the recent upgrade reflects growing confidence in the company's trajectory.
The average price target stands at $45.40, implying 30.6% upside from the current price of $34.77. Price targets range from a low of $41.00 to a high of $53.00, with even the most conservative estimate suggesting double-digit appreciation potential. The tight clustering of targets around the mean indicates strong conviction among the analyst community.
The unanimous Strong Buy rating and improved sentiment trend reflect analyst confidence in SUBLOCADE's growth trajectory, the company's market leadership position in long-acting injectable OUD treatments, and its attractive valuation metrics. With a forward P/E of just 7.50 and gross margins exceeding 85%, analysts see significant value despite the stock's recent volatility and technical weakness.
The Barchart Technical Opinion has deteriorated sharply heading into earnings, currently showing an 88% Sell signal compared to 72% Sell one week ago and a neutral Hold signal one month ago. This rapid weakening suggests mounting technical pressure as the stock approaches its quarterly report.
Timeframe Analysis:
Trend Characteristics: The trend environment is characterized by Soft strength and Average direction, suggesting a lack of conviction in the current downward pressure despite the bearish signals across all timeframes.
The stock is trading at $34.77, positioned below its 20-day ($34.97), 50-day ($35.32), 100-day ($37.44), and 200-day ($35.65) moving averages, though it remains above its 5-day ($34.77) and 10-day ($34.33) averages. This configuration indicates short-term stabilization within a broader downtrend.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $34.77 | 50-Day MA | $35.32 |
| 10-Day MA | $34.33 | 100-Day MA | $37.44 |
| 20-Day MA | $34.97 | 200-Day MA | $35.65 |
The technical setup heading into earnings is cautionary, with the stock trapped below all major intermediate and long-term moving averages while technical indicators flash sell signals across multiple timeframes. The 100-day moving average at $37.44 represents significant overhead resistance, while the recent breakdown below the 200-day average at $35.65 suggests the stock has lost a key support level. However, the stabilization above short-term averages and the "Soft" trend strength reading indicate the selling pressure may be losing momentum. Given the stock's history of explosive post-earnings moves averaging nearly 10%, the current technical weakness could either amplify downside risk if results disappoint or set up a sharp reversal if the company delivers another beat-and-raise quarter.